健康受试者MRI衍生心肌细胞外容积的汇总估计值与参考正常区间:系统综述与Meta分析
该系统综述与Meta分析纳入56项研究共1851名健康受试者,汇总MRI衍生心肌细胞外容积(ECV)为25.6%(95%CI 25.2-26.0%),正常区间19.6-31.6%;ECV随年龄每年增加0.03%,且受序列类型显著影响,MOLLI序列正常区间19.9-31.9%,ShMOLLI序列20.3-33.5%。
要点
- 健康受试者MRI衍生ECV汇总值为25.6%(95%CI 25.2-26.0%),参考正常区间19.6-31.6%。
- ECV正常区间因序列而异:MOLLI为19.9-31.9%,ShMOLLI为20.3-33.5%。
- ECV随年龄每年增加0.03%(p=0.038),与对比剂类型/剂量及场强无关。
核心结论
- 健康受试者心肌汇总ECV为25.6%,每增加1岁ECV增加0.03%;MOLLI序列正常区间19.9-31.9%,ShMOLLI序列20.3-33.5%。
研究设计与样本
- 系统综述与Meta分析,注册于PROSPERO并按PRISMA报告;2017年10月检索MEDLINE/EMBASE,最终分析56篇文章共1851名健康受试者,年龄16-68岁,体质指数23-28 kg/m2,左心室射血分数58-74%,对比剂剂量0.075-0.200 mmol/kg;采用随机效应模型计算汇总ECV,Newcastle-Ottawa量表评估研究质量,亚组/Meta回归分析技术及生物学协变量,Egger检验评估发表偏倚风险。
诊断标准与关键数值
- 汇总ECV为25.6%(95%CI 25.2-26.0%),正常区间19.6-31.6%,计算方式为汇总ECV±2倍所有研究标准差的均方根;序列类型对汇总ECV有显著影响(p=0.003),MOLLI序列正常区间19.9-31.9%,ShMOLLI序列20.3-33.5%;异质性高(I2=92%);ECV随年龄轻度增加(β=0.03%,p=0.038),随男性比例轻度降低(β=-0.02%,p=0.053);对比剂类型/剂量、采集时间及磁场强度对汇总ECV无显著影响(p>0.093);48/56项研究(86%)质量为中等或高;无发表偏倚风险(p=0.728)。
临床应用与阅片要点
- 作者结论指出健康受试者心肌汇总ECV为25.6%,每增加1岁ECV增加0.03%;MOLLI序列ECV正常区间为19.9-31.9%,ShMOLLI序列为20.3-33.5%;要点指出MRI衍生ECV与对比剂类型/剂量及场强无关,但依赖于成像序列。
局限性
- 异质性高(I2=92%);随男性比例轻度降低的关联未达统计学显著(β=-0.02%,p=0.053)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To estimate the MRI-derived myocardial extracellular volume (ECV) in healthy subjects together with reference normality interval.
METHODS: The study was registered on PROSPERO and reported according to PRISMA. In October 2017, a systematic search (MEDLINE/EMBASE) was performed for articles reporting MRI-derived ECV in healthy subjects. The pooled ECV (pECV) with 95% confidence interval (CI) was calculated using the random-effect model; the normality interval was calculated as pECV ± 2 root mean square of all study standard deviations. The Newcastle-Ottawa scale was used for assessing study quality, subgroup/meta-regression analyses for technical/biological covariates, and Egger test for publication bias risk.
RESULTS: Of 282 articles, 56 were analyzed totaling 1851 subjects with age 16-68 years, body mass index 23-28 kg/m2, and left ventricular ejection fraction 58-74%. Contrast dose varied from 0.075 to 0.200 mmol/kg. Heterogeneity was high (I2 = 92%). The pECV was 25.6% (95% CI 25.2-26.0%) with a normality interval of 19.6-31.6%. pECV was slightly increasing with age (β = 0.03%, p = 0.038) and slightly decreasing with the percentage of males (β = - 0.02%, p = 0.053). Sequence type significantly (p = 0.003) impacted on pECV: the normal interval was 19.9-31.9% for MOLLI and 20.3-33.5% for ShMOLLI. Contrast type/dose, time of acquisition, and magnetic field strength did not significantly impact pECV (p > 0.093). Quality was moderate or high in 48/56 studies (86%). No risk of publication bias (p = 0.728).
CONCLUSIONS: Myocardial pECV in healthy subjects was 25.6%, increasing by 0.03% for each year of age. The ECV normality interval was 19.9-31.9% for MOLLI and 20.3-33.5% for ShMOLLI.
KEY POINTS: • The pooled estimate of normal MRI-derived ECV based on 1851 subjects was 25.6%, slightly increasing with age and slightly decreasing with the percentage of males. • MRI-derived ECV was independent of contrast type/dose and field strength but dependent on the imaging sequence. • The modeled normality reference interval of MRI-derived ECV was 19.9-31.9% for the MOLLI sequence and 20.3-33.5% for the ShMOLLI sequence.
引用
- Sardanelli F, Schiaffino S, Zanardo M, et al. Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis. Eur Radiol. 2019. PMID: 31049734. doi:10.1007/s00330-019-06185-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。